In Part 1 of this webinar series, we will discuss the implications of current regulatory trends and how this impacts the expectations for bacterial retention testing (BRT) studies. We will also address the challenges of applying critical process parameters (CPP) to the design of a bacterial retention study, as a part of the aseptic filtration validation process. The recent regulatory observations will be discussed as cases.
In this webinar, you will learn:
The 2nd webinar in this series, Case Studies: How to Incorporate Critical Process Parameter (CPP), is also available.
Somasundaram G (Som)
MilliporeSigma
Senior Consultant
Som is a consultant with customers for regulatory compliance, closed processing, and other areas in biopharmaceutical applications. He is also a member of PDA and ISPE industry associations. Som has worked in different functions within MilliporeSigma for the last 19 years, including heading technology management, tech service, BioReliance® filter validation lab, commercial role, and business development areas. He also worked for a year in QA/QC as well as obtained one year of academic experience in microbiology.
Ramesh Raju
MilliporeSigma
Head of Operations BioReliance® Validation Services Lab
Ramesh is currently the head of operations, BioReliance® Validation Services lab of MilliporeSigma at Bangalore which provides aseptic filter validation services to Asia & Oceana, Middle East, Africa, LATAM, and Mexico along with the Indian subcontinent. Previously, he was managing the technology management team in India at MilliporeSigma. Ramesh has more than 20 years of experience in aseptic processing and validation of injectables. He is currently pursuing his doctorate program in extractable and leachable from Kuvempu University.
Pharma and biopharma manufacturing
Duration:1hr
Language:English
Session 1:presented October 5, 2021
To continue reading please sign in or create an account.
Don't Have An Account?